All News 4basebio PLC

Equities

Market Closed - London S.E. Other stock markets 11:35:17 2024-04-25 am EDT			5-day change	1st Jan Change
1,120 ^GBX	+4.67%		+8.21%	+64.71%

Apr. 10	4basebio to supply synthetic DNA for mRNA vaccine program	AN
Apr. 10	4Basebio plc Announces the Supply of Its opDNA? DNA Products into Tier 1 Pharma Client's Vaccine Program	CI

4basebio to supply synthetic DNA for mRNA vaccine program	Apr. 10	AN
4basebio Plc - 4basebio announces the supply of its opDNA™ DNA products into Tier 1 Pharma client's vaccine program	Apr. 10	PR
4Basebio plc Announces the Supply of Its opDNA? DNA Products into Tier 1 Pharma Client's Vaccine Program	Apr. 10	CI
4basebio updates markets on "key milestone" with client	Mar. 21	AN
4basebio Plc - 4basebio client's Phase I clinical trials for opDNA™ based mRNA vaccine	Mar. 21	PR
Alpha Real Trust says in "robust" financial shape	Mar. 01	AN
4basebio wins DNA supply contract to support RNA therapies	Mar. 01	AN
4basebio Wins Synthetic DNA Supply Tender from CPI	Mar. 01	MT
4basebio Plc - 4basebio awarded tender to deliver research and GMP-grade synthetic DNA in CPI's tender process for supplying its RNA Centre of Excellence	Mar. 01	PR
4basebio Plc - Holding(s) in Company	Feb. 06	PR
4basebio Plc - Holding(s) in Company	Feb. 06	PR
4basebio Plc - Holding(s) in Company	Feb. 06	PR
4basebio Plc - Holding(s) in Company	Feb. 06	PR
4basebio Plc - Exercise of Options	Feb. 06	PR
4basebio Plc - Holding(s) in Company	Feb. 05	PR
4basebio Plc - Holding(s) in Company	Feb. 05	PR
4basebio Plc - Holding(s) in Company	Feb. 05	PR
4basebio Plc - Directors' Dealings	Feb. 05	PR
4basebio Plc - Long-Term Incentive Plan and Exercise of Options	Feb. 02	PR
4basebio interim loss widens as research costs increase	23-09-21	AN

No results for this search